Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
67%(4 trials)

Phase Distribution

Ph phase_4
1
14%
Ph not_applicable
1
14%
Ph phase_2
3
43%
Ph phase_1
1
14%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Other(1)

Detailed Status

Completed6
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

completed686%
unknown114%

Recent Activity

0 active trials
Showing 5 of 7
completed

Abnormal Uterine Bleeding and Progestin-only Contraceptives

NCT03398811
completedphase_2

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

NCT02412436
completedphase_4

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

NCT01463202
completednot_applicable

Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women

NCT00828542
unknownphase_2

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

NCT02335203
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03398811

Abnormal Uterine Bleeding and Progestin-only Contraceptives

Completed
NCT02412436Phase 2

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Completed
NCT01463202Phase 4

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

Completed
NCT00828542Not Applicable

Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women

Completed
NCT02335203Phase 2

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

Unknown
NCT02894151Phase 2

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

Completed
NCT01791413Phase 1

Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7